Scientists are hot on the trail of a new tuberculosis treatment that a small study suggests might one day offer an alternative to battle this deadly lung disease, even if it’s resistant to today’s two main drugs. There haven’t been new medications to treat TB in four decades. But the experimental three-drug combination, revealed Monday at the International AIDS Conference, is one of a list of promising compounds under intense testing around the world.
